Diisopropylethylamine → HCID 45254766, compound

HRID 872423Notes

Reaction equation

HRID 872423 reaction equation
[NH2:1][C:2]1[N:3]=[CH:4][N:5]([CH2:7][CH2:8][O:9][C:10]2[C:19]3[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=3)[C:13]([NH:20][C:21]([NH:23][C:24]3[N:28]([C:29]4[CH:34]=[CH:33][C:32]([CH3:35])=[CH:31][CH:30]=4)[N:27]=[C:26]([C:36]([CH3:39])([CH3:38])[CH3:37])[CH:25]=3)=[O:22])=[CH:12][CH:11]=2)[CH:6]=1.CCN(C(C)C)C(C)C.[CH3:49][O:50][CH2:51][C:52](Cl)=[O:53]>C(Cl)Cl>[C:36]([C:26]1[CH:25]=[C:24]([NH:23][C:21](=[O:22])[NH:20][C:13]2[C:14]3[C:19](=[CH:18][CH:17]=[CH:16][CH:15]=3)[C:10]([O:9][CH2:8][CH2:7][N:5]3[CH:6]=[C:2]([NH:1][C:52](=[O:53])[CH2:51][O:50][CH3:49])[N:3]=[CH:4]3)=[CH:11][CH:12]=2)[N:28]([C:29]2[CH:34]=[CH:33][C:32]([CH3:35])=[CH:31][CH:30]=2)[N:27]=1)([CH3:39])([CH3:38])[CH3:37]

Participants

5

Procedure

To a suspension of 1-(4-(2-(4-amino-1H-imidazol-1-yl)ethoxy)naphthalen-1-yl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea (Intermediate I) (50 mg, 0.095 mmol) in DCM (2.0 mL) was added DIPEA (33 μl, 0.191 mmol) and 2-methoxyacetyl chloride (10 μl, 0.105 mmol). The mixture was stirred at RT overnight and then partitioned between saturated aq NaHCO3 solution (5.0 mL) and DCM (2.0 mL). The layers were separated through a phase separator cartridge and the organics were collected and evaporated under reduced pressure. The resulting residue was subjected to SCX capture and release and column chromatography (12 g), eluting with 0 to 10% MeOH in EtOAc. Trituration with EtOAc (5.0 mL) gave N-(1-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido) naphthalen-1-yloxy)ethyl)-1H-imidazol-4-yl)-2-methoxyacetamide (Example 24) as a white solid (8 mg, 14%): m/z 596 (M+H)+ (ES+). 1H NMR (400 MHz, DMSO-d6) δ: 1.26 (9H, s), 2.38 (3H, s), 3.29 (3H, s), 3.93 (2H, s), 4.37 (2H, t), 4.47 (2H, t), 6.34 (1H, s), 6.93 (1H, d), 7.34 (2H, m), 7.41-7.45 (3H, m), 7.48-7.62 (4H, m), 7.88 (1H, d), 8.13-8.15 (1H, dd), 8.54 (1H, s), 8.75 (1H, s), 9.84 (1H, s).

Workup

  1. custompartitioned between saturated aq NaHCO3 solution (5.0 mL) and DCM (2.0 mL)
  2. customThe layers were separated through a phase separator cartridge
  3. customthe organics were collected
  4. customevaporated under reduced pressure
  5. washeluting with 0 to 10% MeOH in EtOAc

Sources & evidence

ORD record
ord-8b0da375b484416d855ad97cc4b89832
Source dataset
uspto-grants-2015_03
Patent number
US08975285B2

Reaction notes

Loading…